Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China · Delayed Price · Currency is CNY 20.36
+0.39 (1.95%)
At close: Sep 5, 2025
Huaxia Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Net Income | 445.11 | 428.64 | 665.93 | 513.82 | 454.92 | 334.46 | Upgrade |
Depreciation & Amortization | 322.78 | 301.53 | 274.36 | 274.11 | 265.64 | 153.65 | Upgrade |
Other Amortization | 82.57 | 76.82 | 58.5 | 49.05 | 50.55 | 63.52 | Upgrade |
Loss (Gain) From Sale of Assets | -5.55 | -3.49 | -11.28 | -1.85 | -0.1 | -1.1 | Upgrade |
Asset Writedown & Restructuring Costs | 12.82 | 12.03 | 6.15 | 0.46 | 1.88 | 1.28 | Upgrade |
Loss (Gain) From Sale of Investments | -57.83 | -65.76 | -87.46 | -14.5 | -8.73 | -2.31 | Upgrade |
Provision & Write-off of Bad Debts | 17.91 | 11.86 | 11.31 | 3.5 | 4.36 | 3 | Upgrade |
Other Operating Activities | 57.47 | 46.79 | 50.96 | 34.53 | 38.05 | -4.35 | Upgrade |
Change in Accounts Receivable | 312.28 | 330.57 | -61.85 | -69.24 | -12.08 | 22.24 | Upgrade |
Change in Inventory | 1.06 | 56.96 | -33.06 | -31.23 | -18.74 | -22.16 | Upgrade |
Change in Accounts Payable | -358.92 | -363.65 | 108.83 | 4.01 | 12.95 | 7.71 | Upgrade |
Change in Other Net Operating Assets | - | - | - | 0.77 | 5.16 | 6.42 | Upgrade |
Operating Cash Flow | 813.37 | 820.3 | 961.24 | 769.98 | 798.02 | 590.62 | Upgrade |
Operating Cash Flow Growth | -14.84% | -14.66% | 24.84% | -3.51% | 35.11% | 32.96% | Upgrade |
Capital Expenditures | -243.2 | -279.59 | -448.43 | -235.31 | -173.63 | -163.29 | Upgrade |
Sale of Property, Plant & Equipment | 1.61 | 2.37 | 1.72 | 3.56 | 1.79 | 2.28 | Upgrade |
Cash Acquisitions | -89.41 | -421.41 | 1.82 | -10.31 | - | -1.07 | Upgrade |
Divestitures | 1.56 | 1.56 | 28.55 | - | - | 3.62 | Upgrade |
Investment in Securities | -456.85 | -132.84 | 2,247 | -2,795 | -2.02 | 537.7 | Upgrade |
Other Investing Activities | 84.19 | 82.42 | 78.21 | - | 6.11 | -544.06 | Upgrade |
Investing Cash Flow | -702.09 | -747.5 | 1,909 | -3,037 | -167.74 | -164.82 | Upgrade |
Long-Term Debt Issued | - | - | - | 26.13 | - | 160 | Upgrade |
Long-Term Debt Repaid | - | -195.04 | -144.66 | -143.14 | -122.43 | -426.21 | Upgrade |
Net Debt Issued (Repaid) | -206.1 | -195.04 | -144.66 | -117.01 | -122.43 | -266.21 | Upgrade |
Issuance of Common Stock | - | - | 2.1 | 3,053 | - | 2.34 | Upgrade |
Repurchase of Common Stock | -25.03 | -199.65 | - | - | - | - | Upgrade |
Common Dividends Paid | -91.71 | -91.71 | -156.8 | - | -0.16 | -8.73 | Upgrade |
Other Financing Activities | -61.82 | -19.75 | -5.13 | -284.65 | -57.99 | 4.26 | Upgrade |
Financing Cash Flow | -384.65 | -506.15 | -304.49 | 2,651 | -180.58 | -268.35 | Upgrade |
Net Cash Flow | -273.37 | -433.36 | 2,566 | 384.16 | 449.69 | 157.45 | Upgrade |
Free Cash Flow | 570.18 | 540.71 | 512.81 | 534.68 | 624.38 | 427.34 | Upgrade |
Free Cash Flow Growth | 10.72% | 5.44% | -4.09% | -14.37% | 46.11% | 127.33% | Upgrade |
Free Cash Flow Margin | 13.86% | 13.43% | 12.78% | 16.54% | 20.38% | 16.99% | Upgrade |
Free Cash Flow Per Share | 0.68 | 0.64 | 0.61 | 0.70 | 0.83 | 0.57 | Upgrade |
Cash Interest Paid | 0.41 | 0.41 | 0.52 | 0.5 | - | - | Upgrade |
Cash Income Tax Paid | 239.35 | 258.37 | 200.68 | 170.18 | 173.68 | 187.02 | Upgrade |
Levered Free Cash Flow | 591.31 | 464.23 | 425.75 | 447.72 | 475.76 | 299.86 | Upgrade |
Unlevered Free Cash Flow | 619.64 | 492.43 | 449.53 | 471.7 | 499.27 | 303.74 | Upgrade |
Change in Working Capital | -61.91 | 11.88 | -7.24 | -89.12 | -8.55 | 42.48 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.